Welcome to our dedicated page for Nanalysis Sci news (Ticker: NSCIF), a resource for investors and traders seeking the latest updates and insights on Nanalysis Sci stock.
Nanalysis Scientific Corp (NSCIF) delivers innovative portable NMR spectrometers and security solutions for industrial and research markets. This dedicated news hub provides investors and industry professionals with timely updates on corporate developments and technological advancements.
Access official press releases covering earnings results, product launches, strategic partnerships, and operational milestones. Our curated feed ensures efficient tracking of developments in both core business segments: scientific equipment innovation and security service contracts.
Key updates include regulatory filings, technology patents, and major maintenance agreements for critical infrastructure. All content is sourced directly from company disclosures to ensure accuracy and compliance with financial reporting standards.
Bookmark this page for streamlined monitoring of NSCIF's progress in advancing magnetic resonance technology and expanding its global service footprint. Check regularly for essential updates impacting market positioning and operational strategy.
Nanalysis Scientific Corp. will participate in two upcoming investment conferences. The first is the LD Micro Conference on June 7, 2022, at 4:30 PM ET, where investors can engage in 1x1 meetings. The second event is the OTCQX Best 50 Virtual Investor Conference on June 16, 2022, at 1:00 PM ET, also featuring virtual 1x1 sessions. Nanalysis specializes in portable NMR technology and aims to enhance investor engagement through these interactive presentations.
Nanalysis Scientific Corp. reported its first-quarter results for 2022, highlighting a consolidated revenue of $5,554K, a 69% increase year-over-year. However, the company faced a net loss of $1,492K, compared to a loss of $467K in the same period last year. The gross margin declined to 60% from 64%. Significant developments included a $160 million multi-year service contract with CATSA and a $4,985,000 funding commitment from the Canadian government.
Nanalysis Scientific Corp. announced a six-year contract valued at $160 million with the Canadian Air Transportation Security Authority (CATSA) to provide service and maintenance for security screening equipment. This contract, effective from May 25, 2022, may be renewed for an additional five years, creating a potential eleven-year recurring revenue opportunity. The project’s phase-in process is underway, targeting completion by the end of Q1 2023. This win is expected to enhance Nanalysis's footprint in the security vertical and contribute to shareholder value.
Nanalysis Scientific Corp. will host a conference call on May 31, 2022, at 5:00 PM ET to discuss the quarterly results ending March 31. The call is accessible via phone and a listen-only webcast. The Annual General Meeting (AGM) is set for June 22, 2022, at 11:00 AM ET, with shareholders encouraged to vote by proxy due to health concerns. Nanalysis, trading as OTCQX: NSCIF, specializes in portable NMR and MRI technologies.
Nanalysis Scientific Corp. (OTCQX:NSCIF) will present at the Planet MicroCap Showcase 2022 on May 4, 2022, at 5:30 PM PT in Las Vegas. CEO Sean Krakiwsky will lead the presentation and engage in one-on-one investor meetings. The event will be accessible via a live webcast. Nanalysis is recognized for its innovative portable NMR technology, serving industries such as pharma, biotech, and oil & gas. The company continues to enhance its product offerings, including a new 100MHz NMR device, reinforcing its position in the market.
Nanalysis Scientific Corp. announced its financial results for Q4 and full year of 2021, showcasing a remarkable 104% revenue growth to $16,043K. The company improved its net loss to $1,772K from a previous loss, while gross margins slightly decreased from 66% to 64%. Strategic highlights included a $4.98 million funding commitment from the Canadian government and acquisitions of K’Prime Technologies and Quad Systems. The firm is optimistic about future growth, supported by a healthy balance sheet and strong product demand.
Nanalysis Scientific Corp. will release its fourth quarter and full year results for the year ending December 31, 2021 on Thursday, April 28, 2022, followed by a conference call at 5 PM ET. CEO Sean Krakiwsky and CFO Luke Caplette will lead the call. Investors can participate via phone or through a webcast. The release will provide insights into the company's financial performance and future strategies as a leader in portable MRI and NMR technology.
Nanalysis Scientific Corp. (OTCQX:NSCIF, TSXV:NSCI) will be presenting at NobleCon18 on April 22, 2022, at 12:30 PM ET in Hollywood, Florida. CEO Sean Krakiwsky will also hold breakout sessions on April 20 and April 21 at various times. The presentation will be available via a high-definition video webcast the following day, accessible through Noble Capital Markets' website and Channelchek. Nanalysis specializes in portable Nuclear Magnetic Resonance (NMR) devices and aims to expand its market reach in multiple industries.
Nanalysis Scientific Corp. has secured $4,985,000 from the Canadian government to enhance its manufacturing operations and expand into global markets for nuclear magnetic resonance products. This funding, provided through Prairies Economic Development Canada, will be accessed over three years with interest-free repayments starting on September 1, 2025. The CEO, Sean Krakiwsky, expressed gratitude for this support, indicating it will help drive growth and innovation while mitigating supply chain risks. The Company focuses on developing portable NMR spectrometers for various industries.
FAQ
What is the current stock price of Nanalysis Sci (NSCIF)?
What is the market cap of Nanalysis Sci (NSCIF)?
